NCT05015192View on ClinicalTrials.gov

Single Ascending Dose Study of NH102 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

August 12, 2021

Primary Completion Date

January 11, 2022

Study Completion Date

January 11, 2022

Conditions
Depression
Interventions
DRUG

NH102

tablets, orally

DRUG

Placebo

tablets, orally

Trial Locations (1)

Unknown

Shanghai Mental Health Center, Shanghai

Sponsors
All Listed Sponsors
lead

Jiangsu Nhwa Pharmaceutical Co., Ltd.

INDUSTRY

NCT05015192 - Single Ascending Dose Study of NH102 in Healthy Subjects | Biotech Hunter | Biotech Hunter